Free Trial

Manitex Capital (MNX) Insider Trading & Ownership

C$0.07 -0.01 (-12.50%)
(As of 12/18/2024 05:28 PM ET)

Manitex Capital (CVE:MNX) Insider Buying and Selling Activity

Current
Insider Ownership
Percentage
61.15%
Number Of
Insiders Buying
(Last 3 Years)
1
Amount Of
Insider Buying
(Last 3 Years)
C$13,100.00
Number Of
Insiders Selling
(Last 3 Years)
0
Get MNX Insider Trade Alerts

Want to know when executives and insiders are buying or selling Manitex Capital stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily.

MNX Insider Buying and Selling by Quarter

Manitex Capital Insider and Congressional Trades History

Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
12/15/2022Steve SaviukDirectorBuy2,000C$0.60C$1,200.00
10/7/2022Steve SaviukDirectorBuy3,000C$0.50C$1,500.00
10/4/2022Steve SaviukDirectorBuy20,000C$0.52C$10,400.00
(Data available from 1/1/2013 forward)

MNX Insider Trading Activity - Frequently Asked Questions

The list of insiders at Manitex Capital includes Steve Saviuk. Learn more on insiders at MNX.

61.15% of Manitex Capital stock is owned by insiders. Learn more on MNX's insider holdings.

Manitex Capital Key Executives

  • Mr. Steven Saviuk CA (Age 65)
    Chairman, President & CEO
    Compensation: $17.05k
  • Ms. Helen Saviuk CA
    CFO & Director
  • Mr. Ronald S. Perry CA (Age 68)
    CPA, Secretary
  • Mr. Kristof Biniecki
    Vice President of Scientific Affairs - Valeo Pharma Inc
  • Mr. Marc F. Leger (Age 65)
    Executive Vice President of Commercial Operations - Valeo Pharma Inc
    Compensation: $144.89k
  • Nathalie Therrien
    Vice-President of QA & Regulatory Affairs - Valeo Pharma Inc.
  • Mr. Luc Mainville M.B.A (Age 60)
    M.B.A., Senior VP & CFO of Valeo Pharma Inc
    Compensation: $135k


This page (CVE:MNX) was last updated on 12/22/2024 by MarketBeat.com Staff
From Our Partners